Genscript Biotech Corporation (HKG:1548)
Hong Kong · Delayed Price · Currency is HKD 34.82
-0.74 (-2.08%)
Oct 14, 2026, 4:08 PM HKT
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of 79.41 billion as of October 14, 2026. It is the 2,159th most valuable company in the world and the 114th biggest in Hong Kong. Its market cap has increased by 120.49% in one year.
Market Cap
79.41B
Enterprise Value
75.79B
Revenue
6.63B
Global Rank
Country Rank
#114 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 79.41B, an increase of 3,659.80%. That is a compound annual growth rate of 39.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 79.41B | 192.42% |
| Dec 31, 2025 | 27.15B | 28.72% |
| Dec 31, 2024 | 21.10B | -49.96% |
| Dec 29, 2023 | 42.16B | -19.78% |
| Dec 30, 2022 | 52.56B | -27.50% |
| Dec 31, 2021 | 72.50B | 229.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 204.12B |
| Innovent Biologics | 153.38B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.50B |
| Sino Biopharmaceutical | 91.99B |
| Akeso | 87.42B |
| RemeGen | 56.22B |
| Biocytogen Pharmaceuticals (Beijing) | 40.24B |
| 3SBio | 35.99B |